Professor Mark Good
Projects as PI
- An evaluation of steric hindrance of APP processing by 2B12 as a treatment for amyloid-related pathology in a preclinical model of Alzheimer's disease (04/01/2008 - 30/09/2011)
- Assessment of AT1R antibody (24/05/2023 - 25/11/2023)
- Does probiotic use influence brain and behaviour (01/01/2010 - 31/12/2012)
- Exploring ACE-2 as a novel therapeutic target for Alzheimer's disease (01/07/2016 - 30/06/2019)
- Exploring ACE-2 as a novel therapeutic target for Alzheimer's disease (01/07/2021 - 30/06/2022)
Projects as Co-Investigator
- Attention and Predictive Learning (01/01/2010 - 30/06/2013)
- Determination of the affinity of the potential therapeutic antibody for Alzheimer's disease, 2B3, for amyloid precursor protein (01/03/2014 - 30/06/2014)
- Dietary intervention for Alzheimer's disease: The molecular basis for beneficial effects of omega-3 fatty acids (01/10/2005 - 28/02/2011)
- Ensuring quality maternal care in an adverse environment (01/01/2017 - 31/12/2019)
- Integrated Neuroscience (01/10/2014 - 30/09/2019)